Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER J MANCUSO

Allopathic & Osteopathic Physicians Dermatology

NPI
1255725529
CMS profile
5284114
Location
NASHUA, NH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$4,645.15

194 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,645.15 194

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 194 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER J MANCUSO

NPI 1255725529 · CMS profile ID 5284114

Allopathic & Osteopathic Physicians / Dermatology

NASHUA, NH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 194 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1255725529?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER J MANCUSO, NPI 1255725529, CMS profile ID 5284114. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 194 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1255725529?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). CHRISTOPHER J MANCUSO, NPI 1255725529, CMS profile ID 5284114. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 194 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1255725529?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
CHRISTOPHER J MANCUSO, NPI 1255725529, CMS profile ID 5284114, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 194 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1255725529?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

194 matching records · $4,645.15 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 194 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 194.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Genentech USA, Inc. $26.1906/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950774025 CMS
Amgen Inc. $23.6306/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939868763 CMS
Novartis Pharmaceuticals Corporation $3.1206/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893931333 CMS
ABBVIE INC. $8.5705/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087791 CMS
PFIZER INC. $21.3105/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949628455 CMS
Amgen Inc. $19.3605/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939868765 CMS
Novartis Pharmaceuticals Corporation $24.4905/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893931329 CMS
PFIZER INC. $21.7505/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949133129 CMS
LEO Pharma Inc. $21.7405/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 936250595 CMS
Amgen Inc. $39.4905/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939868761 CMS
PFIZER INC. $2.9605/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949646311 CMS
ABBVIE INC. $28.2305/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087789 CMS
ABBVIE INC. $8.6605/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087787 CMS
LEO Pharma Inc. $22.1205/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 936250590 CMS
ABBVIE INC. $26.0505/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087785 CMS
Novartis Pharmaceuticals Corporation $23.8805/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893931349 CMS
ABBVIE INC. $27.6205/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087783 CMS
GENZYME CORPORATION $31.1605/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939079993 CMS
ABBVIE INC. $127.3305/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087781 CMS
Janssen Biotech, Inc. $35.9905/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886168029 CMS
PFIZER INC. $3.2705/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949632589 CMS
Novartis Pharmaceuticals Corporation $19.0204/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893931325 CMS
ABBVIE INC. $23.6004/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087779 CMS
Amgen Inc. $66.5004/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939868767 CMS
LEO Pharma Inc. $20.0504/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 936250577 CMS
LEO Pharma Inc. $8.2104/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 936250583 CMS
Novartis Pharmaceuticals Corporation $1.3704/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893931337 CMS
LEO Pharma Inc. $12.1504/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 936250571 CMS
ABBVIE INC. $28.9504/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087775 CMS
ABBVIE INC. $5.8804/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087777 CMS
LEO Pharma Inc. $19.9604/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 936250567 CMS
PFIZER INC. $21.3404/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949582391 CMS
LEO Pharma Inc. $9.9104/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 936250561 CMS
LEO Pharma Inc. $24.8204/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 936250555 CMS
Novartis Pharmaceuticals Corporation $10.5604/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893931317 CMS
Novartis Pharmaceuticals Corporation $2.8504/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893931321 CMS
Sun Pharmaceutical Industries Inc. $19.8804/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947746561 CMS
ABBVIE INC. $22.6704/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087773 CMS
ABBVIE INC. $9.2504/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087771 CMS
Lilly USA, LLC $21.6404/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917950639 CMS
Janssen Biotech, Inc. $30.4403/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886168035 CMS
Galderma Laboratories, L.P. $24.9603/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 952284863 CMS
Amgen Inc. $24.9003/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939868769 CMS
Novartis Pharmaceuticals Corporation $5.9703/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893931313 CMS
ABBVIE INC. $29.8303/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087769 CMS
GENZYME CORPORATION $63.1403/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939079981 CMS
LEO Pharma Inc. $23.9003/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 936250549 CMS
ABBVIE INC. $22.0903/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891087767 CMS
LEO Pharma Inc. $21.7603/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 936250543 CMS
Lilly USA, LLC $20.9303/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917952097 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,281.46 141
PY2020 $3,083.81 119
PY2021 $3,863.14 156
PY2022 $4,645.15 194
PY2023 $1,505.17 55
PY2024 $2,427.45 80
PY2025 $2,304.11 75

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $135,535.96 15

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 CSL Behring $500.00 09/25/2024 Non-covered Recipient Entity
ActivMed Practices and Research LLC
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects No dispute reported 06/30/2026 1142324339
Principal investigator 1 CSL Behring $3,000.00 09/25/2024 Non-covered Recipient Entity
ActivMed Practices and Research LLC
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects No dispute reported 06/30/2026 1142324341
Principal investigator 1 CSL Behring $2,000.00 09/25/2024 Non-covered Recipient Entity
ActivMed Practices and Research LLC
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects No dispute reported 06/30/2026 1142324343
Principal investigator 1 CSL Behring $10,000.00 09/25/2024 Non-covered Recipient Entity
ActivMed Practices and Research LLC
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects No dispute reported 06/30/2026 1142324345
Principal investigator 1 CSL Behring $2,000.00 09/25/2024 Non-covered Recipient Entity
ActivMed Practices and Research LLC
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects No dispute reported 06/30/2026 1142324349
Principal investigator 1 CSL Behring $2,000.00 09/25/2024 Non-covered Recipient Entity
ActivMed Practices and Research LLC
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects No dispute reported 06/30/2026 1142324351
Principal investigator 1 Amgen Inc. $25,300.00 09/24/2024 Non-covered Recipient Entity
ACTIVMED PRACTICES AND RESEARCH LLC
ASCEND P3 AD Extension No dispute reported 06/30/2026 1096308997
Principal investigator 1 UCB SA $10,376.00 09/24/2024 Non-covered Recipient Entity
ALLCUTIS RESEARCH, INC
A Phase 3, open-label, parallel group, multicenter, extension study evaluating the long-term treatment of bimekizumab in study participants with moderate to severe hidradenitis suppurativa No dispute reported 06/30/2026 1153201348
Principal investigator 1 UCB SA $179.26 09/17/2024 Non-covered Recipient Entity
ALLCUTIS RESEARCH LLC.
A Phase 3, open-label, parallel group, multicenter, extension study evaluating the long-term treatment of bimekizumab in study participants with moderate to severe hidradenitis suppurativa No dispute reported 06/30/2026 1153204662
Principal investigator 1 UCB SA $9,787.00 08/20/2024 Non-covered Recipient Entity
ALLCUTIS RESEARCH, INC
A Phase 3, open-label, parallel group, multicenter, extension study evaluating the long-term treatment of bimekizumab in study participants with moderate to severe hidradenitis suppurativa No dispute reported 06/30/2026 1153204126
Principal investigator 1 Amgen Inc. $16,852.00 07/26/2024 Non-covered Recipient Entity
ACTIVMED PRACTICES AND RESEARCH LLC
VOYAGER P3 AD Vaccine Study No dispute reported 06/30/2026 1096316334
Principal investigator 1 Amgen Inc. $736.89 05/28/2024 Non-covered Recipient Entity
ACTIVMED PRACTICES AND RESEARCH LLC
ASCEND P3 AD Extension No dispute reported 06/30/2026 1096308999
Principal investigator 1 Amgen Inc. $1,181.04 04/26/2024 Non-covered Recipient Entity
ACTIVMED PRACTICES AND RESEARCH LLC
VOYAGER P3 AD Vaccine Study No dispute reported 06/30/2026 1096316332
Principal investigator 1 Amgen Inc. $46,954.00 04/20/2024 Non-covered Recipient Entity
ACTIVMED PRACTICES AND RESEARCH LLC
VOYAGER P3 AD Vaccine Study No dispute reported 06/30/2026 1096316328
Principal investigator 1 Amgen Inc. $4,669.77 01/11/2024 Non-covered Recipient Entity
ACTIVMED PRACTICES AND RESEARCH LLC
VOYAGER P3 AD Vaccine Study No dispute reported 06/30/2026 1096316336